Answer Capsule
Corebridge Financial is a mixed fit for life insurance with bipolar disorder. Two of seven platforms named it during ranking discovery, and it finished ninth overall with an average listed rank of 6.0. Its strongest case is a two-path structure: Select-a-Term for applicants stable enough to pass full underwriting, and Guaranteed Issue Whole Life as a no-health-question fallback for ages 50–80. The main limitation is that no platform found published bipolar-specific underwriting standards, verified guaranteed-issue pricing, or evidence that Corebridge is more lenient on bipolar disorder than competitors. Most platforms recommended broker-assisted comparison before applying.
Research Snapshot
| Field | Finding |
|---|---|
| Platform mentions in ranking stage | 2 of 7 platforms (google, perplexity) |
| Share of included platform responses | 28.6% |
| Average listed rank | 6.0 |
| Best listed rank | 5 (google) |
| Relevant product/model/plan | Select-a-Term term life; Guaranteed Issue Whole Life (final expense) |
| Overall use-case fit | Good (1 platform); Mixed (6 platforms) — 7 platforms analyzed |
| Research date | 2026-09-22 |
Why Corebridge Financial Qualified for This Study
Questions This Section Answers
- Why did Corebridge Financial qualify for this bipolar disorder life insurance study when only 2 of 7 platforms named it?
- Is Corebridge Financial worth considering for life insurance if you have bipolar disorder and need both underwritten and guaranteed options?
Corebridge Financial qualified because it was named by two platforms during ranking discovery and because it offers two distinct underwriting pathways relevant to this buyer. Google listed it at rank 5 and Perplexity at rank 7, producing an average listed rank of 6.0 and a final rank of 9 [1]. Its 28.6% platform share is well below the leaders in this category, so it qualified as a secondary consideration rather than a top recommendation.
The qualification rests on product structure rather than bipolar-specific expertise. Corebridge publicly offers term, permanent, and final-expense life insurance, and states that some policies may be delivered quickly or without a medical exam [3]. Its Select-a-Term product is described as flexible term coverage with multiple duration choices [4]. Separately, Corebridge Direct states its guaranteed issue whole life insurance does not require a medical exam or health questions to qualify [2].
The deterministic identity audit noted that one or more fetched domains were not corroborated by brand name or site identity metadata and were not used as official identity signals, and that company-name variants were collapsed onto one canonical brand before minimum-mention qualification. Buyers should treat the brand-to-product mapping as platform-reported rather than independently confirmed.
The Product, Model, Plan, or Service Most Relevant to Life Insurance for Bipolar Disorder
Questions This Section Answers
- Which Corebridge Financial product should a buyer with bipolar disorder choose: Select-a-Term or Guaranteed Issue Whole Life?
- Does Corebridge Financial Select-a-Term require a medical exam for an applicant with bipolar disorder?
Two Corebridge products matter for this use case, and they serve opposite ends of the bipolar underwriting spectrum.
Select-a-Term is a fully underwritten level term policy. Corebridge describes it as flexible term coverage with multiple duration choices [5], and one platform reported 18 duration choices ranging from 10 years, 15 through 30 years, and 35 years [6]. A product highlights document lists an accelerated death benefit rider at no additional premium on eligible plans [7]. SelectQuote documentation confirms Corebridge requires a life insurance medical exam as well as a medical questionnaire for non-guaranteed-issue products [8].
Guaranteed Issue Whole Life is a final-expense-style permanent policy. Corebridge Direct states it requires no medical exam or health questions [9]. Multiple platforms reported the same structure: ages 50–80, roughly $5,000–$25,000 in coverage, and a two-year graded death benefit period [10]. One platform reported that if death occurs in the first two years from non-accidental causes, the beneficiary receives 110% of premiums paid [14].
A naming conflict runs through the evidence. The ranking-stage recommendation named "AIG Select-a-Term," while Corebridge currently markets Select-a-Term. Corebridge states it was formerly AIG Life & Retirement, but the exact current product name, policy form, and issuing insurer should be confirmed [15]. The requested "Corebridge Financial guaranteed issue life insurance" product was not identified as a specific current policy with verified age limits, face amounts, premiums, or state availability [15].
What the AI Platforms Agreed About
Questions This Section Answers
- What do AI platforms agree on about Corebridge Financial for a bipolar disorder applicant?
- Is Corebridge Financial's guaranteed issue whole life policy a genuine no-health-question option for bipolar disorder?
Platforms agreed on four points, though the agreement is strong rather than unanimous.
First, Corebridge offers a genuine no-underwriting fallback. Corebridge Direct states its guaranteed issue whole life does not require a medical exam or health questions [16], and independent reviews repeat the same structure [17].
Second, that fallback is small and slow to pay full benefits. Platforms consistently reported a $5,000–$25,000 face amount range, ages 50–80, and a two-year graded benefit period [17]. One platform noted the product is not ideal unless the buyer is uninsurable elsewhere, because better options exist if underwritten coverage is possible [21].
Third, Select-a-Term is fully underwritten and requires medical evidence. SelectQuote documentation confirms a medical exam and questionnaire are required for non-guaranteed-issue products [22], and Corebridge's own disclosures state premiums depend on evidence of insurability [23].
Fourth, no platform found published bipolar-specific underwriting rules. Corebridge's official product pages reviewed did not state bipolar-specific underwriting rules or guaranteed-issue death-benefit limits for this use case [24], and no authoritative public source reviewed disclosed underwriting treatment specifically for bipolar disorder [25].
Where the AI Platforms Disagreed or Were Uncertain
Platforms disagreed on how favorable Corebridge actually is for mental health applicants, and the disagreement is material.
Policygenius, cited by one platform, states that people with mental health conditions "may have a hard time finding their best rates with Corebridge" [26]. That contrasts with Corebridge being included in a general list of major carriers willing to approve anxiety or depression applicants at standard rates with single-medication stability [27]. Another platform reported that Corebridge is not good for mental disorders [28], while a different platform described Corebridge as relatively strong for some higher-risk underwriting including anxiety and mood disorders, labeling that reviewer opinion rather than guaranteed bipolar-specific approval [29].
Underwriting flexibility claims conflict as well. One platform reported that Corebridge is recognized as a substandard risk specialist willing to table-rate moderate mental health conditions rather than decline them [30], and that traditional guidelines allow up to two medications for mood disorders where other carriers restrict to one [31]. Another platform reported that bipolar disorder is excluded from accelerated fluidless underwriting and must go through fully underwritten manual processing [32], and that bipolar and manic depression are automatic exclusions for simplified or non-medical fast-track underwriting with American General/Corebridge [33].
Financial-strength ratings also conflict. Corebridge reports A.M. Best A and S&P A+ ratings for its principal life insurers as of April 8, 2026 [34]. One platform reported S&P Global assigns BBB+ with a negative outlook as of 2026, and that the status of the rating review during a 2026 corporate transaction is unclear [35]. Another platform reported complaints to state regulators approximately three times the industry average from the AIG era [36].
Pricing is the largest uncertainty. No bipolar-specific premium, underwriting surcharge, approval class, or guaranteed-issue price was publicly verified [37]. One platform reported guaranteed-issue examples around $22–$32 per month for a female age 50 at $5,000 coverage [38], but that is a platform-reported figure, not a verified Corebridge quote.
Use-Case-Specific Features and Capabilities
Questions This Section Answers
- What features does Corebridge Financial Select-a-Term offer a bipolar disorder applicant who needs flexible coverage lengths?
- Does Corebridge Financial offer accelerated underwriting to an applicant with a bipolar disorder diagnosis?
The most relevant capability is term-length flexibility. Corebridge describes Select-a-Term as allowing a customized coverage period, including 18 duration choices ranging from 10 years, 15 through 30 years, and 35 years [39]. One platform reported issue ages 20–80 and a minimum $100,000 face amount [41]. This lets a buyer match coverage to income replacement, mortgage, or dependent-support needs rather than buying more term than required.
Conversion is the second capability. Select-a-Term policies can be converted to permanent life insurance without a new medical exam [42], and one platform reported conversion is available before age 70 [43]. For a bipolar applicant, locking in coverage during a stable period and retaining conversion rights has practical value if future episodes occur.
Accelerated underwriting is the most contested capability. Corebridge says it offers accelerated underwriting under AU+ for term, indexed universal life, and guaranteed universal life policies [44], and states some term policies may use accelerated underwriting and may be issued without a medical exam [45]. However, Corebridge also states simplified underwriting is not guaranteed, may have higher premiums and lower coverage, and that guaranteed-issue coverage may have low limits, high premiums, and a waiting period for non-accidental death [45]. One platform reported bipolar disorder is excluded from accelerated fluidless underwriting entirely [46], and another reported bipolar and manic depression are automatic exclusions for simplified fast-track underwriting with American General/Corebridge [47]. Buyers should treat accelerated underwriting eligibility as unverified for this diagnosis.
Corebridge's own field underwriting guide highlights bipolar disorder, psychotic disorders, and suicide attempts as significant psychiatric and risk factors [48]. That is company-owned evidence that the diagnosis receives underwriting scrutiny, not a statement of acceptance criteria.
Pricing, Fees, Contracts, and Ongoing Costs
Questions This Section Answers
- How much does Corebridge Financial Select-a-Term cost per month for a bipolar disorder applicant, and is any bipolar-specific rate published?
- What cancellation, contestability, and graded-benefit terms apply to Corebridge Financial coverage for someone with bipolar disorder?
No verified bipolar-specific price exists in the supplied evidence. Pricing confidence is low across every platform that addressed it.
For Select-a-Term, premiums depend on age, coverage amount, term length, tobacco status, underwriting class, medical history, and policy options [49]. Corebridge's public rate examples are for selected healthy or preferred applicants and should not be used to estimate the premium for someone diagnosed with bipolar disorder [50]. One platform reported term rates are often in the top 5–10 nationally for healthier applicants [51], but that competitive positioning is documented for standard or low-risk health classes, not table-rated mental health cases [51].
For Guaranteed Issue Whole Life, one platform reported fixed premiums by age and gender, with examples around $22–$32 per month for a female age 50 at $5,000 coverage [52]. Another reported premiums are level and guaranteed not to increase [53]. Because guaranteed issue accepts applicants without health underwriting, it generally costs more per dollar of death benefit than fully underwritten coverage [54].
Contract terms carry several restrictions. A current Corebridge direct-term disclosure states the policy may be contested for two years for material misstatements or omissions, and that the death benefit may be limited to return of premium for suicide during the first two years [49]. Guaranteed-issue policies may contain a limited-benefit or graded-death-benefit period, commonly about two years for non-accidental death [55]. One platform reported the graded structure refunds 110% of premiums for natural-cause death in years one and two, with full benefit after two years and accidental death covered in full from day one [56]. Free-look, lapse, reinstatement, surrender, renewal, and cancellation terms are policy- and state-specific and were not verified [49].
No specific application fee was verified, and any policy, rider, modal-payment, or administrative charges should be confirmed in the illustration and policy contract [49].
Best Suited For
Questions This Section Answers
- Who is Corebridge Financial best suited for when buying life insurance with bipolar disorder?
- Is Corebridge Financial a good choice for a bipolar disorder applicant who has been declined for underwritten coverage elsewhere?
Corebridge is best suited to three buyer profiles, based on platform convergence.
First, applicants seeking medically underwritten term coverage with a customized term duration. Select-a-Term's 18 duration choices let a buyer align the coverage period with a specific financial obligation [57].
Second, applicants with stable treatment, consistent medical care, reliable daily functioning, and no recent severe episodes who are willing to compare a formal underwriting decision [59]. One platform described the target profile as Bipolar II applicants with two or more years of medication stability, no recent hospitalizations, and employment, who are willing to accept table-rated premiums if needed [60].
Third, applicants who need a backup final-expense or guaranteed-issue option after traditional underwriting is declined, if an applicable Corebridge product is available in their state and age range [59]. One platform framed this as individuals with severe bipolar disorder who need guaranteed approval without medical underwriting, and those already declined by fully underwritten carriers [61].
A fourth profile appears in one platform's assessment: buyers who want to combine a full-underwriting application with a known no-underwriting fallback from the same insurer [62].
Probably Not Best Suited For
Questions This Section Answers
- Who should not choose Corebridge Financial for life insurance with bipolar disorder?
- Is Corebridge Financial a poor fit for a bipolar disorder applicant who needs more than $25,000 in guaranteed coverage?
Corebridge is probably not the best fit for four buyer situations.
Applicants needing high coverage with guaranteed acceptance regardless of age, health history, or recent hospitalization [63]. Guaranteed issue caps at roughly $25,000, which will not substitute for a standard term need [64].
Applicants seeking transparent bipolar-specific eligibility rules or published premiums before submitting medical information [63]. No platform found published bipolar-specific underwriting guidelines, and one platform noted the company does not provide online quotes, so prospective buyers must contact an agent directly [65].
Applicants with recent hospitalization, uncontrolled symptoms, serious substance-use history, recent self-harm, or inconsistent treatment who may obtain better terms through a specialist broker comparing multiple impaired-risk carriers [63]. One platform reported that Bipolar I with any hospitalization history rarely qualifies for standard rates and is likely table-rated or declined under full underwriting [66].
Applicants under age 50 who need guaranteed issue. One platform reported Corebridge guaranteed issue is limited to ages 50–80, while other carriers offer broader age ranges [67].
When Another Option May Be Better
Questions This Section Answers
- When is a different carrier better than Corebridge Financial for a bipolar disorder applicant?
- Should a bipolar disorder applicant use an independent broker instead of applying directly to Corebridge Financial?
Another option may be better in five situations, and most platforms pointed toward broker-assisted comparison rather than a direct Corebridge application.
When the applicant has recent hospitalization or an acute episode. One platform reported a 6–24 month postponement is typical across carriers, and specialist brokers can identify lenient carriers faster than a direct application [68].
When the applicant has Bipolar I and is seeking standard rates. One platform reported more specialized carriers exist and that Corebridge is not noted as lenient for Bipolar I relative to the market [69].
When the applicant needs coverage above $25,000 through a guaranteed-issue route. One platform reported Corebridge caps guaranteed issue at $25,000, so the buyer would need to pursue Select-a-Term with full underwriting instead [70].
When the applicant is under age 50 and needs guaranteed issue. One platform named Colonial Penn, TruStage, and Gerber Life as offering broader age ranges [70].
When the applicant wants no-exam term coverage. One platform reported Corebridge requires an exam for Select-a-Term, while some competitors offer no-exam term up to $500,000 or higher [71].
The strongest cross-platform recommendation was to work with an independent impaired-risk broker. One platform stated that working with an independent broker experienced in high-risk and mental health underwriting improves odds meaningfully by pre-screening the situation against the carriers most likely to approve it before formal application [72]. Another reported that 85–90% of applicants with mental health issues secure coverage on some basis, with 50–300% premium increases, reinforcing the value of shopping multiple carriers [73].
Questions to Verify Before Buying
Questions This Section Answers
- What should a buyer confirm with Corebridge Financial before signing a bipolar disorder life insurance contract?
- Can a buyer get an informal underwriting inquiry from Corebridge Financial before submitting a formal bipolar disorder application?
The supplied research produced a consistent verification list across platforms. Buyers should confirm each item in writing before applying.
Underwriting and eligibility: whether the application will be underwritten by American General Life Insurance Company, The United States Life Insurance Company, or another affiliated insurer; whether Select-a-Term is currently available in the buyer's state and what policy form and term durations apply; and how current stability, episode history, medications, hospitalizations, psychotherapy, employment, daily functioning, substance use, and any self-harm history will affect the decision [74].
Records and process: what medical records, attending-physician statement, prescription database report, or psychiatric records will be requested; whether an informal or anonymous underwriting inquiry can be completed before submitting a formal application; and what underwriting class, exclusions, rating, postponement period, or decline outcome is likely based on the specific history [74].
Pricing and contract terms: the exact premiums at the offered rating including modal charges and rider costs; whether the policy is convertible, until what date, and whether new evidence of insurability is required; the guaranteed renewal premiums after the initial term; and the suicide, contestability, lapse, reinstatement, free-look, and cancellation provisions in the actual policy contract [74].
Guaranteed-issue specifics: whether a guaranteed-issue product exists in the buyer's state and age range, the maximum face amount, and what graded-benefit or waiting-period provisions apply [74]. One platform added that buyers should confirm the exact graded benefit schedule by year and whether Corebridge offers any simplified-issue product as a middle option between full underwriting and guaranteed issue [75].
One platform also recommended confirming whether Corebridge underwriting differentiates between Bipolar I and Bipolar II, and how medication compliance and treatment gaps such as a three-month medication lapse are evaluated [76].
Final AI Consensus Verdict
Corebridge Financial is a mixed fit for life insurance with bipolar disorder, and the platform consensus reflects that rating: six of seven platforms rated it mixed, with only google rating it good.
The case for considering it rests on structure, not specialization. Select-a-Term offers genuine term-length flexibility and a conversion path without a new medical exam [77]. Guaranteed Issue Whole Life offers a real no-health-question fallback for ages 50–80 with a two-year graded benefit [79]. Together they give a bipolar applicant both an underwriting attempt and a fallback from one carrier.
The case against treating it as a primary recommendation is stronger. No platform found published bipolar-specific underwriting standards [81]. One platform reported that people with mental health conditions may have a hard time finding their best rates with Corebridge [83]. Guaranteed issue is capped near $25,000 with a graded benefit period [80]. Ratings and complaint data conflict across sources [84]. And no verified bipolar-specific price exists anywhere in the evidence.
The practical conclusion most platforms reached is that Corebridge is a reasonable option within a broader broker-assisted comparison, not a primary recommendation for bipolar-specific coverage [87]. Buyers should compare at least three carriers and confirm underwriting outcomes before committing.
How This Review Was Produced
This review synthesizes fit-research responses from seven AI platforms that evaluated Corebridge Financial for the specific use case of Life Insurance for Bipolar Disorder. Each platform returned a structured assessment covering product relevance, underwriting stance, pricing, contract terms, strengths, limitations, and verification questions.
Two of the seven platforms named Corebridge during ranking discovery, producing a 28.6% platform share, an average listed rank of 6.0, and a best listed rank of 5. The remaining five platforms evaluated fit without naming the entity in their ranking stage.
All platform outputs are platform-reported and were not independently verified. Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Where a platform supplied no citation for a factual claim, that claim is labeled platform-reported or unverified.
Methodology Limitations
Several limitations constrain this review.
No platform found published bipolar-specific underwriting guidelines from Corebridge. A diagnosis of bipolar disorder may lead to additional underwriting review, a higher premium, a reduced offer, postponement, or decline, and the outcome cannot be predicted from the public information reviewed [88].
Guaranteed-issue availability and exact product details were not verified for any specific state, age, or coverage amount [88]. Product availability, riders, issuing insurer, and contractual terms may vary by state [89].
Pricing confidence is low across all platforms. Published healthy-applicant price examples are not representative of this buyer [90], and no verified public quote for this use case was found [88].
Platform-reported research dates differ from the authoritative run date. Six platforms reported 2026-09-22, while deepseek reported 2026-06-01. Platform-reported dates are provenance metadata and do not independently prove freshness.
The deterministic identity audit noted that one or more fetched domains were not corroborated by brand name or site identity metadata and were not used as official identity signals, and that company-name variants were collapsed onto one canonical brand before minimum-mention qualification.
One platform operated without search enabled (deepseek), so its claims rest on model knowledge rather than retrieved evidence and require explicit verification before being described as current facts.
Finally, platform agreement does not prove product quality. Agreement here reflects shared reliance on overlapping public sources, not independent verification of Corebridge's underwriting behavior.
Sources
Company-Owned Sources
- Advertising Disclosures | American General Term Life: https://agtl.uat.corebridgedirect.com/advertising-disclosures
- Corebridge Financial - Financials - Ratings: https://investors.corebridgefinancial.com/financials/Ratings/default.aspx
- Corebridge (AIG) Guaranteed Issue Whole Life Insurance: Your 2024 Guide: https://www.corebridgedirect.com/Direct/blog/guaranteed-issue-whole-life-insurance-guide.htm
- Guaranteed Issue Whole Life Insurance - Corebridge Direct: https://www.corebridgedirect.com/Direct/guaranteed-issue-whole-life-insurance.htm
- Guaranteed Issue Whole Life Insurance: https://www.corebridgedirect.com/guaranteed-issue-whole-life-insurance
- Life Insurance Field Underwriting Guide: https://www.corebridgefinancial.com/content/dam/marketing/corporate/en/us/documents/brochure/life-insurance-field-underwriting-guide.pdf
- Term Life Insurance | Corebridge Financial - Individual: https://www.corebridgefinancial.com/content/marketing/corporate/en/corp-site/what-we-offer/life-insurance/term-life-insurance.html
- Corebridge Financial — Life Insurance: https://www.corebridgefinancial.com/home
- Behind the scenes of life insurance underwriting: https://www.corebridgefinancial.com/insights-education/behind-the-scenes-of-life-insurance-underwriting
- Life insurance research insights: https://www.corebridgefinancial.com/insights-education/life-insurance-insights
- Top Rated Life Insurance Company | Corebridge Financial: https://www.corebridgefinancial.com/newsroom/2024/corebridge-rated-top-life-insurance-company
- Life Insurance | Corebridge Financial: https://www.corebridgefinancial.com/what-we-offer/life-insurance
Additional AI research evidence90 records
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c12
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record perplexity:c10
- AI research evidence record anthropic:src-2
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.8
- AI research evidence record openai:c1
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c1
- AI research evidence record google:1.2.8
- AI research evidence record anthropic:src-3
- AI research evidence record anthropic:src-2
- AI research evidence record openai:c4
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:src-20
- AI research evidence record anthropic:src-25
- AI research evidence record grok:web:2
- AI research evidence record perplexity:c4
- AI research evidence record google:2.3.7
- AI research evidence record google:2.4.3
- AI research evidence record google:2.3.4
- AI research evidence record google:2.3.6
- AI research evidence record openai:c6
- AI research evidence record anthropic:src-29
- AI research evidence record anthropic:src-7
- AI research evidence record openai:c1
- AI research evidence record grok:web:4
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record grok:web:11
- AI research evidence record anthropic:src-5
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c5
- AI research evidence record google:2.3.4
- AI research evidence record google:2.3.6
- AI research evidence record google:2.1.1
- AI research evidence record openai:c4
- AI research evidence record openai:c7
- AI research evidence record anthropic:src-31
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c5
- AI research evidence record deepseek:c3
- AI research evidence record openai:c5
- AI research evidence record anthropic:src-6
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c1
- AI research evidence record anthropic:src-20
- AI research evidence record kimi:maplevalleyins-1
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:src-29
- AI research evidence record kimi:terminsurancebrokers-3
- AI research evidence record anthropic:src-6
- AI research evidence record anthropic:src-10
- AI research evidence record anthropic:src-44
- AI research evidence record anthropic:src-6
- AI research evidence record anthropic:src-2
- AI research evidence record anthropic:src-17
- AI research evidence record kimi:theglobeandmail-4
- AI research evidence record openai:c1
- AI research evidence record kimi:maplevalleyins-1
- AI research evidence record anthropic:src-20
- AI research evidence record openai:c2
- AI research evidence record anthropic:src-5
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record openai:c1
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:src-20
- AI research evidence record openai:c6
- AI research evidence record anthropic:src-29
- AI research evidence record anthropic:src-7
- AI research evidence record anthropic:src-17
- AI research evidence record openai:c1
- AI research evidence record openai:c3
- AI research evidence record openai:c7
Independent Sources
- Best Life Insurance for Depression & Anxiety (2024) – Policygenius: http://policygenius.com/life-insurance/mental-health/
- Life Insurance Companies That Will Accept People With Bipolar Disorder: https://clearsurance.com/blog/life-insurance-with-bipolar-disorder
- Corebridge (formerly AIG) Guaranteed Issue Whole Life Review - Guaranteed Life Insured: https://guaranteedlifeinsured.com/corebridge-aig-guaranteed-issue-review/
- How to Get Life Insurance for Bipolar Disorder: https://hinermangroup.com/bipolar-disorder-life-insurance/
- Corebridge Financial Life Insurance Review (A Rated, 2024: https://insurancy.com/life-insurance/reviews/corebridge-financial/
- Corebridge Life Insurance Review 2026 (Formerly AIG: https://ogletreefinancial.com/blog/aig-american-general-life-insurance-company-review/
- Getting Life Insurance with Mental Health Conditions: What You Need to Know | Penny Pincher: https://pennypincher.com/articles/insurance/life/life-insurance-with-mental-health-conditions
- Mental Health Conditions and Life Insurance: https://terminsurancebrokers.com/life-insurance-answers/high-risk-life-insurance/mental-health-life-insurance/
- AIG (Corebridge Financial) Life Insurance Review (2026: https://unitedeaglesfinancial.com/carriers/aig/
- The Life Underwriting Guide - Agent Support Group: https://www.agentsupportgroup.com/documents/asg-underwriting-guide.pdf
- Corebridge Financial Life Insurance Review 2025 | Bankrate: https://www.bankrate.com/insurance/reviews/corebridge-financial/
- Life Insurance for Bi Polar | Get a Chief Underwriter's Guidance: https://www.diversifiedquotes.com/life-insurance-for-bi-polar/
- FASTER! - Empower Brokerage Underwriting Guidelines: https://www.empowerbrokerage.com/documents/faster-underwriting-guide.pdf
- Accelerated Underwriting - Fluidless Carriers: https://www.fluidlesscarriers.com/accelerated-underwriting/
- Select-A-Term – Financial Markets Inc: https://www.fmiagent.com/carrier/corebridge-financial/select-a-term/
- Corebridge Financial Life Insurance Review – Forbes Advisor: https://www.forbes.com/advisor/insurance/corebridge-financial-life-insurance-review/
- Corebridge Financial Life Insurance Review – Forbes Advisor: https://www.forbes.com/advisor/life-insurance/corebridge-financial-life-insurance-review/
- AIG / Corebridge Financial Life Insurance Review 2026: https://www.insuranceandestates.com/aig-life-insurance-reviews/
- Corebridge Financial life insurance ratings and review 2026 | Insure.com: https://www.insure.com/companies/corebridge-financial-life-insurance.html
- Investopedia — Life Insurance and Mental Health / Bipolar Disorder: https://www.investopedia.com/articles/pf/08/life-insurance-mental-illness.asp
- Investopedia — Guaranteed Issue Life Insurance: https://www.investopedia.com/terms/g/guaranteed-issue-life-insurance.asp
- AIG Life Insurance Review 2026: Cost, Coverage & Ratings: https://www.lifequotesweb.com/aig-life-insurance-review-2026/
- Life Insurance With Bipolar Disorder: Can You Get Approved?: https://www.maplevalleyins.com/life-insurance-with-bipolar-disorder/
- Life Insurance With Bipolar Disorder: Coverage Options and Costs: https://www.moneygeek.com/insurance/life/life-insurance-bipolar-disorder/
- Bipolar Life Insurance 2025 Guide - PinnacleQuote: https://www.pinnaclequote.com/blog/life-insurance-bipolar-disorder/
- Corebridge Financial Life Insurance Review: Great Term Rates – Policygenius: https://www.policygenius.com/life-insurance/reviews/corebridge-financial/
- Bipolar Life Insurance Complete 2026 Guide: https://www.reassured.co.uk/life-insurance/bipolar-life-insurance/
- Policy for Person with Bipolar : r/LifeInsurance: https://www.reddit.com/r/LifeInsurance/comments/zh6b1u/policy_for_person_with_bipolar/
- Corebridge Financial Life Insurance Review - RiskQuoter.com: https://www.riskquoter.com/company-reviews/corebridge-financial/
- Life Insurance and Mental Health: 2024 Guide to Getting Coverage: https://www.riskquoter.com/depression-life-insurance/
- How to Beat Life Insurance Table Ratings and Save Big on Coverage: https://www.riskquoter.com/life-insurance-table-ratings/
- Corebridge Financial Life Insurance | SelectQuote: https://www.selectquote.com/life-insurance/carriers/corebridge-financial-life-insurance-company
- Great Life Insurance Tips for those with Bipolar Disorder: https://www.simplelifeinsure.com/life-insurance-bipolar-disorder/
- Sought treatment for mental health? You could struggle to get life insurance: https://www.theglobeandmail.com/investing/personal-finance/article-mental-health-treatment-life-insurance/
- Corebridge Financial Life Insurance (AIG) Review for 2026 | U.S. News: https://www.usnews.com/insurance/life-insurance/corebridge-financial
- Corebridge Financial Life Insurance (formerly AIG) Review - WSJ: https://www.wsj.com/buyside/personal-finance/life-insurance/corebridge-financial-life-insurance-review
Additional AI research evidence90 records
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c12
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record perplexity:c10
- AI research evidence record anthropic:src-2
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.8
- AI research evidence record openai:c1
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c1
- AI research evidence record google:1.2.8
- AI research evidence record anthropic:src-3
- AI research evidence record anthropic:src-2
- AI research evidence record openai:c4
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:src-20
- AI research evidence record anthropic:src-25
- AI research evidence record grok:web:2
- AI research evidence record perplexity:c4
- AI research evidence record google:2.3.7
- AI research evidence record google:2.4.3
- AI research evidence record google:2.3.4
- AI research evidence record google:2.3.6
- AI research evidence record openai:c6
- AI research evidence record anthropic:src-29
- AI research evidence record anthropic:src-7
- AI research evidence record openai:c1
- AI research evidence record grok:web:4
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record grok:web:11
- AI research evidence record anthropic:src-5
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c5
- AI research evidence record google:2.3.4
- AI research evidence record google:2.3.6
- AI research evidence record google:2.1.1
- AI research evidence record openai:c4
- AI research evidence record openai:c7
- AI research evidence record anthropic:src-31
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c5
- AI research evidence record deepseek:c3
- AI research evidence record openai:c5
- AI research evidence record anthropic:src-6
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c1
- AI research evidence record anthropic:src-20
- AI research evidence record kimi:maplevalleyins-1
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:src-29
- AI research evidence record kimi:terminsurancebrokers-3
- AI research evidence record anthropic:src-6
- AI research evidence record anthropic:src-10
- AI research evidence record anthropic:src-44
- AI research evidence record anthropic:src-6
- AI research evidence record anthropic:src-2
- AI research evidence record anthropic:src-17
- AI research evidence record kimi:theglobeandmail-4
- AI research evidence record openai:c1
- AI research evidence record kimi:maplevalleyins-1
- AI research evidence record anthropic:src-20
- AI research evidence record openai:c2
- AI research evidence record anthropic:src-5
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record openai:c1
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:src-20
- AI research evidence record openai:c6
- AI research evidence record anthropic:src-29
- AI research evidence record anthropic:src-7
- AI research evidence record anthropic:src-17
- AI research evidence record openai:c1
- AI research evidence record openai:c3
- AI research evidence record openai:c7
Other Sources
Additional AI research evidence90 records
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c12
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record perplexity:c10
- AI research evidence record anthropic:src-2
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.8
- AI research evidence record openai:c1
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c1
- AI research evidence record google:1.2.8
- AI research evidence record anthropic:src-3
- AI research evidence record anthropic:src-2
- AI research evidence record openai:c4
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:src-20
- AI research evidence record anthropic:src-25
- AI research evidence record grok:web:2
- AI research evidence record perplexity:c4
- AI research evidence record google:2.3.7
- AI research evidence record google:2.4.3
- AI research evidence record google:2.3.4
- AI research evidence record google:2.3.6
- AI research evidence record openai:c6
- AI research evidence record anthropic:src-29
- AI research evidence record anthropic:src-7
- AI research evidence record openai:c1
- AI research evidence record grok:web:4
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record grok:web:11
- AI research evidence record anthropic:src-5
- AI research evidence record google:1.1.4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c5
- AI research evidence record google:2.3.4
- AI research evidence record google:2.3.6
- AI research evidence record google:2.1.1
- AI research evidence record openai:c4
- AI research evidence record openai:c7
- AI research evidence record anthropic:src-31
- AI research evidence record grok:web:4
- AI research evidence record perplexity:c5
- AI research evidence record deepseek:c3
- AI research evidence record openai:c5
- AI research evidence record anthropic:src-6
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c1
- AI research evidence record anthropic:src-20
- AI research evidence record kimi:maplevalleyins-1
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:src-29
- AI research evidence record kimi:terminsurancebrokers-3
- AI research evidence record anthropic:src-6
- AI research evidence record anthropic:src-10
- AI research evidence record anthropic:src-44
- AI research evidence record anthropic:src-6
- AI research evidence record anthropic:src-2
- AI research evidence record anthropic:src-17
- AI research evidence record kimi:theglobeandmail-4
- AI research evidence record openai:c1
- AI research evidence record kimi:maplevalleyins-1
- AI research evidence record anthropic:src-20
- AI research evidence record openai:c2
- AI research evidence record anthropic:src-5
- AI research evidence record perplexity:c12
- AI research evidence record anthropic:src-6
- AI research evidence record openai:c1
- AI research evidence record deepseek:c1
- AI research evidence record anthropic:src-20
- AI research evidence record openai:c6
- AI research evidence record anthropic:src-29
- AI research evidence record anthropic:src-7
- AI research evidence record anthropic:src-17
- AI research evidence record openai:c1
- AI research evidence record openai:c3
- AI research evidence record openai:c7
Verify this research
Check when the research was run, which platforms were included, and what supports the findings.
- Study date
- September 22, 2026
- Platforms analyzed
- 7
- Source records
- 50
- Ranking mentions
- 2 of 7
- Platform share
- 29%
- Final consensus rank
- #9
Behind the findings
Platforms in this study
- ChatGPT
- Claude
- DeepSeek
- Grok
- Perplexity
- Kimi
- Gemini
Source records
36 independent · 13 company-owned · 1 unclear
Evidence support
39 direct · 9 partial
Keep in mind
Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.
Technical verification details
Use this SHA-256 fingerprint to identify the source snapshot associated with this study.
56201977610c2945a875a6b126f119f0fec8b766325016b32fae0bdd8cfbf890